250+ investors that invest in your industry and stage
Marketplace
Gaming
Community
Proptech
Biotech
Impact
Health Care
FinTech
Energy
Google
Artificial intelligence
Consumer
Climate
Hardware
Sustainability
EdTech
Venture Capital
Real Estate
Digital Media
Finance
Retail
Web3
Music
Video Games
Publishing
Beauty
Android
Education
B2B
Payments
Organic Food
Infrastructure
Franchise
Food and Beverage
Financial Services
Photography
Clean Energy
Big Data
Construction
Biotechnology
Cannabis
Fitness
Travel
Recruiting
Platforms
Mobile Advertising
Hospitality
Automotive
Crowdfunding
Social
Enterprise Software
Medical Device
Wine And Spirits
CleanTech
Mobile Apps
Transportation
InsurTech
Enterprise
Sports
LGBT
Manufacturing
Email
Internet
Local
Social Network
Fashion
Oil and Gas
Social Media
Theatre
Film
Life Science
Wellness
Medical
Non Profit
Art
Legal
Mobile
eSports
Renewable Energy
SaaS
Sporting Goods
Restaurants
Celebrity
Software
Social Impact
Machine Learning
Cryptocurrency
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
United Kingdom
United States
Germany
India
Australia
Canada
New Zealand
South Korea
Ireland
Saudi Arabia
Brazil
Armenia
Qatar
Asia
Sri Lanka
Europe
Belgium
Spain
Hungary
Faroe Islands
Belarus
South Africa
Bahrain
Gibraltar
France
Barbados
Greece
Belize
Vietnam
Hong Kong
Algeria
Ghana
Japan
Denmark
Finland
Estonia
Croatia
China
Bermuda
Chile
Costa Rica
Georgia
Ecuador
Singapore
Bulgaria
Czech Republic
Ethiopia
Middle East
Egypt
Liberia
Kuwait
Philippines
Malaysia
Morocco
Peru
Nicaragua
LATAM
Malta
Liechtenstein
Mexico
Lithuania
Lebanon
Jersey
Myanmar
Africa
Mali
Israel
Panama
Italy
Mauritius
Oceania
Norway
Ukraine
Turkey
Serbia
Sierra Leone
Rwanda
Venezuela
Indonesia
Sweden
Senegal
Tajikistan
Puerto Rico
Portugal
Slovenia
Dominican Republic
Uganda
Bahamas
Taiwan
Togo
Russian Federation
Tanzania
Zimbabwe
San Marino
Uruguay
Namibia
Poland
Azerbaijan
Iceland
El Salvador
Thailand
Tunisia
Zambia
Uzbekistan
United Arab Emirates
Nigeria
Jamaica
Honduras
Bolivia
Isle of Man
Mozambique
Luxembourg
Iraq
Grenada
Albania
Pakistan
Jordan
Romania
Argentina
Bangladesh
Kenya
Kazakhstan
Cayman Islands
Cambodia
Cyprus
Oman
Latvia
Marshall Islands
Austria
Cameroon
Switzerland
Colombia
Guatemala
Seychelles
Angel investors
VC Funds
All investors
Download Find emails Save list

Top 50 Biotech VC (Venture Capital) Funds in Germany in May 2026

A list of 50 VC (Venture Capital) funds that invest in Biotech startups based in Germany. We rank investors based on the number of investments they made in Biotech companies from Germany. We update this investor list every month.

Top 50 Biotech VC (Venture Capital) Funds in Germany in May 2026

Investor Biotech Germany investments
HTGF (High-Tech Gruenderfonds) 45
Boehringer Ingelheim Venture Fund 17
MIG Capital 16
KfW 16
NRW.BANK 15
Bayern Kapital 14
b.value AG 9
Wellington Partners 9
TGFS - Technologiegründerfonds Sachsen 8
IFB Innovationsstarter 8
Techno Venture Management 7
BioMedPartners 7
bmp Ventures 6
eCAPITAL ENTREPRENEURIAL PARTNERS 6
Forbion Capital Partners 6
coparion 6
Creathor Ventures 5
bm-t beteiligungsmanagement thuringen 5
IBB Ventures 5
BayBG Venture Capital 5
Brandenburg Kapital 5
EMBL Ventures 5
German Federal Ministry of Education and Research 4
Amino Collective 4
EQT Ventures 4
Grazia Equity 4
S-Venture Capital Dortmund 4
CPT Capital 4
BlueYard Capital 4
LSP BioVentures 4
better ventures 4
EIC Fund 4
Andera Partners 4
Seed Fonds Aachen 4
Gilde Healthcare 3
Lowercarbon Capital 3
Good Seed Ventures 3
Ananda Impact Ventures 3
EQT Life Sciences 3
TVM Capital 3
M Ventures 3
Possible Ventures 3
Global Asset Fund 3
Think.Health 3
LBBW VC 3
Counteract 3
SFO 3
UVC Partners 3
Agronomics 3
Seventure Partners 3

Reach every investor

Get a list of investors who already back your industry, stage, and country. Emails & phones included.

Find investors — It's Free!
Investor list
HTGF (High-Tech Gruenderfonds)
VC Fund · Bonn, Nordrhein-Westfalen, Germany

High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.

Show more...

Investment focus

  • Software, Biotechnology, Information Technology
  • Seed, Series A, Funding Round
  • Germany, Switzerland, United States

Portfolio highlights

  • CorTec — Reliable products for active implantable device development. We realize your next project with you and offer individual solutions that meet your specific requirements for Medical Devices, especially in neurotechnology.
  • Senodis — The digital transformation of industry is not developed on paper; it requires pioneering work to implement specific solutions and applications off the beaten track. With our experience and our network at the interface between materials research, optical sensors, and digital data analysis, we and our partners provide the missing building blocks forthe connection and digitization of your production.
  • CenterPoint - Connective Software Engineering — CenterPoint was founded in 2000 and is based in Villach, Austria with an additional office in Warsaw, Poland. CenterPoint - Connective Software Engineering develops and markets process control and fault detection and classification software solutions. The company offers cause effect analysis, metrology assessment, and close loop and run to runcontrol services. It's focus are the semiconductors, electronics, and steel and alloy industries.
Show all investments...

Boehringer Ingelheim Venture Fund
VC Fund · Ingelheim Am Rhein, Rheinland-Pfalz, Germany

Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine

Show more...

Investment focus

  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Seed
  • United States, Germany, Belgium

Portfolio highlights

  • Nuevocor — Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts.
  • smartbax — We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.
  • TECregen — TECregen is a biotechnology company that develops thymus-rejuvenating biologics to restore immune function and T-cell responses.
Show all investments...

MIG Capital
VC Fund · München, Bayern, Germany · 3 investments in the past 12 months

MIG Capital is one of the leading German VC Investors. We invest in European Deep Tech and Life Sciences from early to late stage (Seed, Series A, and beyond). We use investments to shape a better tomorrow, today. Our team currently manages 17 MIG public venture capital funds regulated by BaFin, the German financial markets authority. These fundsoperate with more than EUR 1.2 billion capital committed by >60,000 private investors across Germany and Austria.Today, our portfolio consists of 30 companies.

Show more...

Investment focus

  • Biotechnology, Health Care, Therapeutics
  • Series A, Funding Round, Series B
  • Germany, France, Austria

Portfolio highlights

  • AMSilk — AMSilk produces and distributes high-quality silk biopolymers for use in textile products, medical devices, and cosmetics.
  • Look Up Space — Lookup space is the next global leader for space safety, security and sustainability
  • ASTRA Therapeutics — Astra - Therapeutics
Show all investments...

KfW
VC Fund · Frankfurt, Hessen, Germany

KfW gives impetus to economic, social and ecological development worldwide. As a promotional bank under the ownership of the Federal Republic and the Länder (federal states), it offers support to encourage sustainable improvement in economic, social, ecological living and business conditions, among others in the areas of small and medium-sizedenterprise, entrepreneurialship, environmental protection, housing, infrastructure, education finance, project and export finance, and development cooperation.

Show more...

Investment focus

  • Biotechnology, Software, Health Care
  • Series A, Funding Round, Series B
  • Germany, India, Kenya

Portfolio highlights

  • Vectoflow — Vectoflow is an innovative company developing fluid-dynamic metrology devices for fluid flow and dynamics measurement. It offers standardized and customized flow measurement technology that measures the static and total pressure, velocity, and angle of attack of a flow. These products are used in motorsport, aviation, turbine machine development,and research sectors.
  • Electrochaea — Electrochaea is commercializing a disruptive, scalable technology to convert electric power into methane, the principal component of natural gas. Using CO2 as a feedstock gas, power can be efficiently converted to renewable natural gas for power storage, for transportation fuels, or for transmission via a natural gas network. The company licensedtechnology from the University of Chicago and is led by the Nidus Partners, a St. Louis investment group specializing in renewable energy. Mich Hein, a Nidus Managing Partner, serves as CEO.Electrochaea has developed a commercially viable and disruptive solution for utility-scale energy storage, grid balancing, and carbon reuse. Their proprietary process converts low-cost and stranded electricity and carbon dioxide into pipeline-grade renewable gas for direct injection into the existing natural gas grid, a conversion process known as “power-to-gas”.
  • CryoTherapeutics — CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intendsto extend the benefits of cryoenergy to the problem of diseased coronary arteries.
Show all investments...

NRW.BANK
VC Fund · Düsseldorf, Nordrhein-Westfalen, Germany

NRW.BANK is the development bank for the state of North Rhine-Westphalia. It supports its owner – the state of North Rhine-Westphalia – in fulfilling its tasks, notably in the fields of structural, economic, social and housing policy. NRW.BANK pools the promotion and development programmes of the state of North Rhine-Westphalia, the FederalRepublic of Germany and the European Union and combines them with its own equity and debt products and advisory services. It offers the full range of financial products in three areas “Economy”, “Housing”, and “Infrastructure/Municipalities”. NRW.BANK operates in a competitively neutral manner as a partner of banks and savings banks.

Show more...

Investment focus

  • Software, Information Technology, Biotechnology
  • Seed, Series A, Series B
  • Germany, United States, France

Portfolio highlights

  • OSPHIM — OSPHIM is an AI-based technology combines data visualization, precise anomaly detection, and intelligent process setup for injection molding processes
  • paXos — paXos serve three key industries and bring a lot of expertise and know-how from a large number of projects with them. Synergies can be found not only in engineering but also in cross-industry topics such as consulting, project management, training, and personnel management. They provide services like Consulting, Engineering, Project Management,Training, and many more.
  • Co-reactive — Co-reactive is a ClimateTech startup that provides decarbonization of the construction industry at scale. Co-reactive works with suppliers of CO₂ and raw materials, manufacturers of cement and concrete, and certification bodies throughout the value chain to scale from pilot plants to large industrial units in the range of 100–300 kilotons. Feedback
Show all investments...

Bayern Kapital
VC Fund · Landshut, Bayern, Germany

Bayern Kapital (founded at the end of 1995) is a wholly owned subsidiary of the LfA Foerderbank Bayern (Bavaria‘s development bank). Bayern Kapital’s objective is to finance research and development as well as the market launch of new products, product diversifications, and expansion of the market share.The requesting company has to be located inBavaria. Industries are e. g. IT/software, life sciences, new materials, micro-systems and environmental technologies.Bayern Kapital and its funds have invested in more than 250 companies and currently manages funds to the value of EUR 340 m. The five investing funds currently managed by Bayern Kapital are Seedfonds Bayern, Clusterfonds Start-Up!, Innovationsfonds, Innovationsfonds EFRE and Wachstumsfonds Bayern.

Show more...

Investment focus

  • Software, Health Care, Information Technology
  • Seed, Series A, Funding Round
  • Germany, United States, Finland

Portfolio highlights

  • XO Life — XO Life is to build the largest real-world evidence platform for patient insights for all medications and therapies. Together with one of Europe's leading research institutes for patient-centered research, the PROMIS Institute Germany of the Charité, and various pharmaceutical manufacturers, patient experiences are to be recorded in astandardized and systematic manner across a wide range of diseases. Patients are to be enabled to record their therapy course and outcome independently as well as scientifically validated so that these patient insights from real treatment practice can be used in the life science industry and by medical professions.
  • OroraTech — From safeguarding forests and ecosystems to protecting communities and critical assets, OroraTech's advanced technology and reliable insights address challenges, mitigate risks, and drive meaningful impact.
  • Goodly Innovations — Goodly Innovations is the leading regulated industry-focused global Pharma 4.0 provider for extended reality shop floor guidance. From cleanrooms to secondary packaging areas, labs and more, Goodly can help improve Pharma and BioPharma clients efficiency, OEE, quality, training and more
Show all investments...

b.value AG
VC Fund · Dortmund, Nordrhein-Westfalen, Germany

b.value AG are into Biotechnology investments.

Show more...

Investment focus

  • Biotechnology, Manufacturing, Chemical
  • Seed, Funding Round, Series A
  • Germany, Poland

Portfolio highlights

  • PL BioScience — STEM CELL EXPANSION IN SAFE AND REPRODUCIBLE CONDITIONS. We deliver advanced 2D and 3D cell culture solutions based on human Platelet Lysate – for basic research, cellular therapeutics and clinical applications. Choose between different safety grades meeting your needs: Research Grade, GMP Grade or GMP-Clinical Grade.
  • Cultimate Foods — At Cultimate, we are transforming the flavor and aroma industry with natural innovative ingredients.
  • traceless materials — traceless materials offer a holistically sustainable alternative to plastics: 100% biobased on plant residues, compostable under natural conditions, and free of toxic chemicals. For a future free of pollution and waste!
Show all investments...

Wellington Partners
VC Fund · Munich, Bayern, Germany

Wellington Partners is a venture capital firm that invests in technology and life sciences companies, focusing on Digital Media, Software, Electronics & Photonics, Resource Efficiency, and Biotech/Life Sciences. It is committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically leadfinancing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, its own commitment can go as high as € 15 million.Wellington was established in 1998 and has offices in Munich, London, and Zurich.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical
  • Series A, Series B, Funding Round
  • Germany, United States, United Kingdom

Portfolio highlights

  • Hilo — Get stress-free readings round the clock with Hilo's clinically validated blood pressure monitor. Learn more
  • UiPath — Reinvent your workplace with the leading robotic process automation platform and learn how UiPath can help your company become a fully automated enterprise.
  • Nuclidium — NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics.
Show all investments...

TGFS - Technologiegründerfonds Sachsen
VC Fund · Leipzig, Sachsen, Germany

TGFS - Technologiegruenderfonds Sachsen is an early stage VC fund targeting high tech startups with strong growth potential. The fund invests into ventures located in Saxony/Germany, Europe's leading semiconductor cluster. The team has invested into more than 120 companies so far, including more than 40 investments from the currentfund.

Show more...

Investment focus

  • Software, Information Technology, Health Care
  • Seed, Series A, Funding Round
  • Germany, United States

Portfolio highlights

  • CYNiO — We produce specialized and scarcely available isocyanates for the specialty chemicals and R&D sector and the industry.
  • Zepta — Zepta emphasizes "digital solutions and sustainability in pest control." Zepta develops a digital approach for protecting humans from pests.
  • b.sure — b.sure help brands, agencies and event organizers to make their offline events as measurable as their online marketing.
Show all investments...

IFB Innovationsstarter
VC Fund · Hamburg, Hamburg, Germany · 1 investment in the past 12 months

The IFB Innovationsstarter is an innovation funding and investment company of the City of Hamburg providing grants and investments.

Show more...

Investment focus

  • Software, SaaS, Artificial Intelligence
  • Seed, Funding Round, Grant
  • Germany, United States

Portfolio highlights

  • mo:re GmbH — We offer standardized tissue cultures and protocols to better predict drug responses and investigate disease models.
  • 3D Spark — Profitability and Sustainability Aligned using 3D Spark's Platform - Empowering Manufacturing with Insights and Efficiency!
  • DEALCIRCLE — DealCircle is a digital M&A solution and partner of hundreds of M&A advisors. We support in identifying buyers and addressing the market. This provides investors access to a comprehensive deal flow of relevant projects.
Show all investments...

Techno Venture Management
VC Fund · Boston, Massachusetts, United States

Techno Venture Management is a venture capital and private equity firm focused on healthcare industry.

Show more...

Investment focus

  • Biotechnology, Health Care, Pharmaceutical
  • Funding Round, Series B, Series A
  • United States, Germany, United Kingdom

Portfolio highlights

  • Streaming21 — Streaming21 is a solution provider of seamless on-demand and IP broadcasting service platform for connected digital home.
  • Helomics — Helomics® is a comprehensive personalized healthcare company, bringing the next generation of diagnostics to the oncology field. Helomics is dedicated to improving patient outcomes by providing a personalized comprehensive tumor profile utilizing a proprietary set of laboratory platforms that leverage both tissue-based live and fixed cellular basedanalysis allowing physicians to characterize malignant tumors on a personalized basis. Helomics’ novel molecular and cellular markers and bioinformatics services support treatment decisions by providing vital information based on the specific biological processes of each individual’s cancer.
  • Precision Therapeutics — Precision Therapeutics is a pharmaceutical research and development business that develops personalized cancer treatments for patients.
Show all investments...

BioMedPartners
VC Fund · Basel, Basel-Stadt, Switzerland

BioMedPartners is one of the leading European venture capital firms providing private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. They target the entire industry with special focus on pharmaceuticals, biotechnology, diagnostics and medical technology.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • Switzerland, Germany, France

Portfolio highlights

  • ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
  • TOLREMO therapeutics — TOLREMO therapeutics is striving to prevent the development of cancer therapy resistance through its proprietary drug discovery and development platform. Learn more about us.
  • Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
Show all investments...

bmp Ventures
VC Fund · Berlin, Berlin, Germany · 3 investments in the past 12 months

bmp Ventures is an innovative Venture Capital Company from Berlin. Since 1997 we’ve been investing Smart Money in Early Stage and Growth Startups. We finance ingenious business models with outstanding teams, who build fast-growing and sustainably profitable enterprises.

Show more...

Investment focus

  • Software, Information Technology, Manufacturing
  • Seed, Funding Round, Series A
  • Germany, United States, Austria

Portfolio highlights

  • CYNiO — We produce specialized and scarcely available isocyanates for the specialty chemicals and R&D sector and the industry.
  • NorcSi GmbH — Entwicklung von neuartigen Batterietechnologien
  • byte robotics — Byte Robotics developed a springboard innovative software technology for robot program generation.
Show all investments...

eCAPITAL ENTREPRENEURIAL PARTNERS
VC Fund · Münster, Nordrhein-Westfalen, Germany · 2 investments in the past 12 months

eCAPITAL is a venture capital investor that provides early to growth stage funding to technology and deep tech companies.

Show more...

Investment focus

  • Information Technology, Software, Manufacturing
  • Series A, Funding Round, Series B
  • Germany, United States, Italy

Portfolio highlights

  • MOTOR AI — Explore MOTOR Ai's certified, German-engineered autonomous driving technology, delivering reliable and scalable public transportation solutions worldwide.
  • Baobab — Protect your business against cyber attacks
  • node.energy — Mit der Software opti.node wird die dezentrale und klimafreundliche Energieversorgung Ihrer Industrie- und Gewerbestandorte radikal vereinfacht. | node.energy
Show all investments...

Forbion Capital Partners
VC Fund · Naarden, Noord-Holland, The Netherlands

Impacting the future of medicine.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series B, Series A, Series C
  • United States, United Kingdom, The Netherlands

Portfolio highlights

  • NOVAMEAT — NOVAMEAT produces plant-based meat substitutes through advanced food printing and tissue engineering technologies. Join the #novameat movement.
  • CellCentric — CellCentric’s primary programme targets a deubiquitinase (DUB) enzyme which is strongly associated with prostate cancer, a leading cause of mortality among men. The target modulates the androgen receptor pathway and can potentially combat the multiple resistance mechanisms seen with recently approved prostate cancer drugs such Xtandi and Zytiga.The programme also has potential clinical utility in non-small cell lung, breast and colon cancer.
  • Braveheart Bio — Advancing treatments to improve outcomes and quality of life for patients with hypertrophic cardiomyopathy and related heart conditions.
Show all investments...

coparion
VC Fund · Cologne, Nordrhein-Westfalen, Germany · 6 investments in the past 12 months

Coparion provides venture capital to accelerate momentum and growth. With a currently active fund of EUR 275 million, Coparion has the means to do so.Coparion supports entrepreneurial vision with know-how, but without intervening in daily business operations. Thanks to in-depth experience in venture capital and in building companies, the Coparionteam discerns potential and opens up new perspectives. Coparion has the substance, tenacity, and creativity required to mutually manage difficult situations successfully.Coparion only invests with co-investors. The fund invests up to EUR 15M per company, usually in several financing rounds of EUR 0.5-8M each. The investment focus is on German companies in the start-up and early growth phases. Coparion is based in Cologne and Berlin.

Show more...

Investment focus

  • Software, SaaS, FinTech
  • Series A, Seed, Series B
  • Germany, Switzerland, United States

Portfolio highlights

  • Finoa — Finoa is the leading European crypto-asset management platform, empowering businesses and institutions to engage with crypto safely and intuitively.
  • Protembis — ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR.The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures.Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity of TAVR.Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
  • Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
Show all investments...

Creathor Ventures
VC Fund · Bad Homburg, Hessen, Germany

We have been investing at the frontier of technology and science for over 30 years. We know what it takes to succeed.

Show more...

Investment focus

  • Software, Health Care, Biotechnology
  • Series A, Funding Round, Series B
  • Germany, Switzerland, United States

Portfolio highlights

  • Ledgy — Digitize your cap table, automate equity plans and simplify compliance. Find out how leading companies use Ledgy to empower their employees and engage investors.
  • HeyJobs — Intelligent recruiting | more hires with performance marketing | only qualified candidates | fast recruiting success | over 1,500 companies use HeyJobs to find employees
  • Humanoo — HUMANOO | MAKING PEOPLE HEALTHIER! HUMANOO is the digital health platform for employees and insurance clients. We enable our users to improve their physical and mental health. Simple, effective, proven - all in one app. With customized programs and innovative eHealth solutions, we guide our users in the areas of fitness, physio, yoga, mindfulnessand nutrition to their self-imposed goals. For the first time, companies and insurance companies can use comprehensive decentralized analysis to understand the health of their employees or insurance clients and make it a measurable success. Our team currently consists of 65 employees from 15 nations with different talents. In our office in Berlin-Kreuzberg, software developers, designers, marketing and sales specialists work together with sports and nutrition scientists as well as yoga teachers and physiotherapists. What we share is the goal to motivate people to stay healthy.
Show all investments...

bm-t beteiligungsmanagement thuringen
VC Fund · Erfurt, Thuringen, Germany · 3 investments in the past 12 months

bm|t supports innovative and growth-oriented companies in Thuringia with equity investments and venture capital.

Show more...

Investment focus

  • Software, Information Technology, Health Care
  • Seed, Funding Round, Series A
  • Germany, United States

Portfolio highlights

  • Leapter — Leapter is the trust engine for AI agents. Build logic tools for AI Agents and de-risk your AI workflows with visual, executable blueprints for deterministic decisions.
  • warmwind — warmwind operates as an AI operating system for visual process automation.
  • PERCEPTEC — PERCEPTEC is an application-oriented think tank with the aim of accelerating the process of modernization and digitalization of the optometric and ophthalmological sector.
Show all investments...

IBB Ventures
VC Fund · Berlin, Berlin, Germany

Pre-Seed to Series A for Berlin-based founders. Where 30 years of expertise, capital and execution power meet.

Show more...

Investment focus

  • Software, Health Care, Internet
  • Seed, Funding Round, Series A
  • Germany, United States, United Kingdom

Portfolio highlights

  • AnyTax — AnyTax modernises and automates the tax process by creating infrastructure for automated tax solutions that are directly integrated with financial platforms.
  • TastyUrban — TastyUrban is in the process of developing a new generation of restaurant usage and strategy.
  • Lumoview Building Analytics — Lumoview digitizes buildings in 2 seconds per room with a device that can be used by everyone. The data is then analyzed highly automated in the cloud. The connected online platform empowers building owners to take action and improve their buildings and reduce CO2 emissions.
Show all investments...

BayBG Venture Capital
VC Fund · München, Bayern, Germany

Innovative post-revenue startups with first customers trust us as highly reliable investors. We have been an active player in the venture capital market for over 25 years. Due to our evergreen approach, we offer institutional venture capital without the limitations of the usual fund structure. Predominantly we invest straight equity. Additionally,we can offer venture debt to mature startups close to break-even in order to avoid further dilution for founders. Being a private investment company we act as both lead investor or co-investor. We can also fulfill the private lead investor role for public investors like Bayern Kapital. Together we are increasing YOUR company's value.

Show more...

Investment focus

  • Software, Information Technology, Health Care
  • Funding Round, Series A, Series B
  • Germany, Italy, United States

Portfolio highlights

  • DcubeD — Accelerate your space exploration through durable and affordable Release Actuators, Solar Arrays, and Deployables from DCUBED.
  • Parkstory — Parkstory offers fully automated parking solutions that are supported by artificial intelligence.
  • StoryBox — StoryBox provides a Software as a Service solution for businesses to create, share and structure video content to make it searchable. With the system, companies can create and organize smartphone-based videos for any application scenario. Using the app, videos can be created and shared by every employee using templates. The app suggests picturesettings and scene lengths automatically and offers an automated creation which includes corporate design. The content can be stored in the DSGVO-compliant StoryBox cloud and can be accessed, filtered and analyzed from anywhere. Customers include Iveco, Erste Group, Evonik, Alten, and KTM.
Show all investments...

Brandenburg Kapital
VC Fund · Potsdam, Brandenburg, Germany · 3 investments in the past 12 months

With a track record of over 20 years in venture capital and experience from more than 200 investments in numerous companies BFB Brandenburg Kapital GmbH (BFB) is the most active equity investor in Brandenburg. BFB invests in fast-growing technology-orientated companies throughout the whole life-cycle. Target sectors are ICT/Digital Economy,Life Science, MedTech, Proptech, Industrial Applications. BFB invests in companies based in or with facilities in Brandenburg. The current VC fund is financed by the European Regional Development Fund (ERDF) an Investitionsbank des Landes Brandenburg (ILB).

Show more...

Investment focus

  • Software, Information Technology, Health Care
  • Seed, Series A, Funding Round
  • Germany, United Kingdom

Portfolio highlights

  • koppla — koppla is a cloud-based planning and communication tool for LEAN construction sites for both general contractors and subcontractors.
  • ThinkSono — ThinkSono Guidance enables any non-ultrasound trained healthcare professional to scan for blood clots (DVT). It reduces waiting times, negative DVT cases and can be used at the point of care.
  • ALVA Energie — Alva delivers turnkey solar systems with integrated energy, heating, and e-mobility for buildings
Show all investments...

EMBL Ventures
VC Fund · Heidelberg, Baden-Wurttemberg, Germany

EMBL Ventures invest throughout Europe with the aim to build companies that create significant commercial opportunities based on new therapeutic treatment.

Show more...

Investment focus

  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • Germany, Austria, Ireland

Portfolio highlights

  • Arsanis — Arsanis is a clinical-stage biopharmaceutical company focused on applying monoclonal antibody (mAb) immunotherapies to address serious infectious diseases. A deep understanding of the pathogenesis of infection, paired with access to some of the most advanced mAb discovery techniques and platforms available today, has positioned Arsanis to build andadvance a pipeline of novel mAbs with multiple mechanisms of action and high potency against their intended targets.The company’s lead clinical program, ASN100, is aimed at serious Staphylococcus aureus infections and is being evaluated in Phase 2 clinical trial for the prevention of S. aureus pneumonia in high-risk, mechanically ventilated patients. In addition to ASN100, its preclinical pipeline is comprised of mAbs targeting multiple serious bacterial and viral pathogens, including respiratory syncytial virus.Arsanis is a U.S. company headquartered in Waltham, Massachusetts, with European research and preclinical development operations headquartered in Vienna, Austria (Arsanis Biosciences GmbH).
  • Topas Therapeutics — Topas Therapeutics GmbH is a private Hamburg, Germany-based biotechnology company focused on developing products to address areas of major unmet need, including autoimmune diseases, allergies and anti-drug antibodies. The Topas Particle Conjugates technology platform induces antigen-specific immune tolerance by harnessing the liver’s naturalimmunology capabilities. The Company has several proprietary programs; lead product candidate TPM203 has recently entered clinical testing for pemphigus vulgaris, an orphan disease. Other programs are in anti-drug antibodies, celiac disease, Type 1 diabetes, as well as a multiple sclerosis program that is available for partnering.Topas has a research and option agreement with Eli Lilly and Company focused on antigen-specific tolerance induction and a multi-year agreement with Boehringer Ingelheim to collaborate in the field of anti-drug antibodies.Topas’ investors include: Epidarex Capital, Gimv, EMBL Ventures, Evotec and Boehringer Ingelheim Venture Fund.
  • Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
Show all investments...

German Federal Ministry of Education and Research
VC Fund · Bonn, Nordrhein-Westfalen, Germany

The German Federal Ministry of Education and Research funds research programs and institutions, supervises nuclear energy, and establishes educational policy in general.

Show more...

Investment focus

  • Biotechnology, Medical, Health Care
  • Grant, Seed, Series B
  • Germany, United States, Denmark

Portfolio highlights

  • NetBird — Wiretrustee is an open-source VPN platform built on top of WireGuard® making it easy to create secure private networks for your organization or home. It requires zero configuration effort leaving behind the hassle of opening ports, complex firewall rules, VPN gateways, and so forth.
  • CyberTide — CyberTide is an AI-based Data Leak Prevention Solution
  • NVision Imaging Technologies — NVision Imaging Technologies is leveraging advances in quantum physics to enable the first routine, convenient and affordable use of Magnetic Resonance Imaging (MRI) for assessing early patient response to cancer treatment at the metabolic level.
Show all investments...

Amino Collective
VC Fund · Berlin, Berlin, Germany

Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.

Show more...

Investment focus

  • Health Care, Biotechnology, Medical
  • Seed, Pre-Seed, Series A
  • United States, Germany, United Kingdom

Portfolio highlights

  • Hedera Dx — A diagnostics platform that makes liquid biopsies a reality in cancer care
  • Theorema — Autonomous R&D agents for biotech, pharma, chemicals, and materials. Theorema analyzes data, recovers R&D costs, and accelerates discovery. #1 on BixBench.
  • Portal Biotech — Portal has created next generation solutions that address the significant opportunities in protein sequencing and metabolomics
Show all investments...

EQT Ventures
VC Fund · Stockholm, Stockholms Lan, Sweden

EQT Ventures is a European VC fund with just over €2.3 billion in total capital raised. EQT Ventures I launched in May 2016, with commitments totaling €566 million and a simple mission - to be the kind of VC the team would have liked to have had on their own startup journeys. Recognizing that building and growing a company takes more than justcapital, the EQT Ventures team provides founders with support and advice throughout different stages of growth. EQT Ventures doesn't focus on particular markets or industries, but on bold and ambitious founders who have the grit and determination to build global success stories. EQT Ventures II launched in November 2019, with commitments totaling €660 million. EQT Ventures III launched in 2022, with commitments totaling €1.1 billion, making it the biggest European Venture Capital fund committed to early-stage tech startups. The EQT Ventures team is based across six offices in London, Stockholm, Berlin, Paris, Amsterdam, Paris, and San Francisco, taking a locals-with-locals approach and supporting founders on the ground. Motherbrain, EQT Ventures' in-house-developed artificial intelligence (AI) platform, ensures the team has a data-driven approach and has driven more than $100 million in portfolio company investments.

Show more...

Investment focus

  • Software, Artificial Intelligence, Information Technology
  • Series A, Seed, Series B
  • Sweden, Germany, United States

Portfolio highlights

  • Unmind — Unmind is a workplace mental health platform. We empower employees to measure, understand, and improve their mental wellbeing.
  • Stacks — Let agents reconcile, analyze, and explain your financial data. You focus on driving outcomes.
  • Standard Cognition — Standard Cognition is an artificial intelligence platform that allows buyers to grab what they want without having to go to a cashier. It empowers consumers to shop and pay without waiting in line, scanning or stopping to check out. Available to any retailer, the solution helps reduce labor costs, improve the customer experience, and improve profitmargins. It also helps small-size retailers to compete with larger chains and online offerings.Standard Cognition was founded in 2017 and is based in San Francisco, California.
Show all investments...

Grazia Equity
VC Fund · Stuttgart, Baden-Wurttemberg, Germany · 1 investment in the past 12 months

Grazia Equity is a venture Capital firm investing in innovative, technology driven startups with high potential.Based in Stuttgart (Germany), Grazia has been supporting a large number of mostly young companies, often from their foundation to the Initial Public Offering or eventual sale. In contrast to other venture capital firms, theypredominantly work with their own capital that they invest as entrepreneurs.

Show more...

Investment focus

  • Internet, E-Commerce, Biotechnology
  • Series A, Series B, Seed
  • Germany, United States, Switzerland

Portfolio highlights

  • Q.ANT — Q.ANT develops photonic processors for AI and high-performance computing, utilizing light for information processing. The company also produces quantum sensors offering ultra-high magnetic field sensitivity in a compact form factor. These products aim to enable more intelligent and sustainable systems across various sectors like data centers,aerospace, and medical technology.
  • Vytal — Start the Packaging Revolution! We are offering smart & reusable To-Go Packaging-as-a-Service to gastronomy clients & consumers.In Germany the consumption of take-away, convenience and delivery food & drinks is responsible for about 281 kilotons of single-use packaging waste for immediate consumption and is growing at double digitrates. Most of the time, To-Go food containers, snack boxes or coffee cups have a very short life-span of only 30 minutes after which they are tossed into trash (or litter parks, beaches & the ocean). This is not only a giant waste of economic resources as each single use costs between 15 and up to 0,60€ for a stable bowl/box with a lid. It is a horrendous waste of environmental resources (wood, water, crude oil, metals & energy) that are used to produce this packaging. Therefore, a single use packaging not weighing more than 30 grams can easily come with an ecological backpack of more than 8 kilograms when taking into account all the resources used in production (material intensities taken from Wuppertal Institute for Climate, Environment and Energy). Looking at GHG emissions, the picture is similarly bleak: Using CO2 emission factors and the detailed material mix of the single-use packaging waste analyzed by NABU (German Nature and Biodiversity Conservation Union), the 281 thousand tons waste from To-Go consumption generated around 556 thousand tons of CO2 or the equivalent of 195k passenger cars per year (assuming an average distance travelled of 15,000km). With the expected rise of take-away, convenience and delivery food, the related emissions are expected to increase at double digit rates as waste volume is expected to increase and as we saw a shift to plastics relative to cardboard or other materials. While there is a growing awareness of the problem, especially in Germany, there is no scalable solution yet and the commonly used alternative of nature-based & ‘biodegradable’ materials like bagasse or PLA also require many resources for production & transport, and have to be incinerated or go to landfill after use as there is currently no way to compost them.
  • Lumotive — Lumotive is a Seattle-based startup company developing high performance, solid-state lidar for autonomous systems in the automotive, UAV, robotics and related industries. The company's revolutionary beam-steering technology leverages Liquid Crystal Metasurfaces (or LCMs) implemented in mature semiconductor manufacturing processes to deliversmall, inexpensive 3D perception systems with unprecedented performance and reliability. For more information, visit us at www.lumotive.com.
Show all investments...

S-Venture Capital Dortmund
VC Fund · Deutsch, Sachsen, Germany

S-Venture Capital Dortmund aims to fund technology companies and is a German regional investment group.

Show more...

Investment focus

  • Biotechnology, Guides, Genetics
  • Series B, Funding Round, Series A
  • Germany

Portfolio highlights

  • Innolume — Innolume has invented a novel comb laser light engine for short-reach optical interconnects between and within computers. Economical wavelength-division multiplexing (WDM) is enabled by this class of low-cost, low-power Fabry-Perot lasers. WDM, familiar from telecom, provides an efficient alternative to multiple lasers and underutilized parallelfiber/waveguides, reducing short-reach system cost and power.
  • Protagen — Protagen is a precision medicine specialist that support drug development, facilitate treatment strategies and improve patient management. Protagen is at the forefront of immuno-profiling and the discovery of novel autoantibody signatures for autoimmune disease and immuno-oncology. Protagen’s SeroTag® technology identifies biomarkers that address anumber of challenges currently hindering the successful development and broader application of both cancer immunotherapies and novel treatments for autoimmune diseases.The company is a leader in patient stratification for autoimmune disease, having developed disease-specific NavigAID stratification panels that profile individual patient’s autoimmune condition and immune status. This precision medicine approach allows for the development and implementation of more targeted therapies for diseases such as systemic lupus erythematosus (SLE), systemic sclerosis (SSc), rheumatoid arthritis (RA), Sjögren’s syndrome (SjS) and others.
  • Scienion — SCIENION AG is a life science company well positioned in the markets of ultra-low volume liquid handling systems and microarray technologies. They provide their customers with an integrated product portfolio facilitating and improving multiparallel bioanalytics, high throughput screening and high throughput production of microarrays in the genomicsand proteomics fields – from early research to manufacturing.
Show all investments...

CPT Capital
VC Fund · London, England, United Kingdom

Investing in the Future of Protein.We invest in visionary founders creating the future of food and materials.

Show more...

Investment focus

  • Food and Beverage, Biotechnology, Food Processing
  • Series A, Seed, Series B
  • United States, Israel, United Kingdom

Portfolio highlights

  • Shiru — Discover Shiru. We are an Ingredient Company that Identifies and Creates Functional Ingredients for the Plant-Based Industry.
  • Change Bio — Change Bio converts waste methane into proteins to make them more affordable and carbon-negative.
  • Asterix Foods — Asterix Foods is a biotechnology company designed to build protein production using plant-cell culture techniques. The company's platform is developing and growing bioactive proteins for food that are scalable, functional, and complex, enabling users with plant cell-cultured and animal-free proteins.It was founded in 2022 and is located inTel Aviv, Israel.
Show all investments...

BlueYard Capital
VC Fund · Berlin, Berlin, Germany

BlueYard backs founders building the interconnected elements that can become the fabric of our future.

Show more...

Investment focus

  • Software, Biotechnology, Internet
  • Seed, Series A, Funding Round
  • United States, Germany, United Kingdom

Portfolio highlights

  • Biomia — Biomia rationally engineers nature-inspired novel small molecule therapeutics to treat CNS disorders.
  • Meatable — Meatable is a food production company that produces real and guilt-free meat. With one cell, they are revolutionizing the meat industry's impact on climate change and animal welfare. At the same time they increase food security, without compromising the culinary experience of eating tasty, real meat. They aim to satisfy the world'sappetite for meat without harming people, animals, and the planet.It was founded in 2018 and is headquartered in Delft, South Holland, The Netherlands.
  • ZeroPhase — Enabling unmanned mission success through reliable communication
Show all investments...

LSP BioVentures
VC Fund · Cambridge, Massachusetts, United States

Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.

Show more...

Investment focus

  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, Germany, United Kingdom

Portfolio highlights

  • Evommune — Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines in inflammatory diseases.
  • Muna Therapeutics — Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.
  • HotSpot Therapeutics — HotSpot Therapeutics is a biotech startup that focuses on the development of allosteric therapies targeting regulatory sites on proteins. It develops a therapy platform to discover medicines and provide proper treatment to identify hotspots and locate pathway treatments for cancer, metabolic and rare diseases, leverages a database of hotspotstructures, harnessing the power of data science in its multidisciplinary approach to drug discovery, and helps patients to get treatment against several diseases.HotSpot Therapeutics was founded in 2017 and is headquartered in Boston, Massachusetts.
Show all investments...

better ventures
VC Fund · Hamburg, Hamburg, Germany · 3 investments in the past 12 months

At better ventures we invest in early-stage founders who aim to change our world for the better.

Show more...

Investment focus

  • Software, Food and Beverage, E-Commerce
  • Pre-Seed, Seed, Series A
  • Germany, Switzerland

Portfolio highlights

  • nuuEnergy — nuuEnergy is a tech-enabled solution aiming to revolutionize the heat pump installation industry. By leveraging technology and industry expertise, we streamline the purchasing and installation process. Our unique approach, refinanced through innovative strategies, promotes a self-reliant and carbon-neutral lifestyle for all our customers.
  • Ciao Coffee — Ciao Coffee provides a plant-based, bean-free, ready-to-drink iced coffee that is aromatic, refreshing, and designed for sustainability.
  • ALVA Energie — Alva delivers turnkey solar systems with integrated energy, heating, and e-mobility for buildings
Show all investments...

EIC Fund
VC Fund

start-ups, SMEs, technology, co-investment

Show more...

Investment focus

  • Biotechnology, Health Care, Information Technology
  • Pre-Seed, Seed, Funding Round
  • Germany, The Netherlands, Austria

Portfolio highlights

  • Filuta AI — Operationalized Composite Artificial Intelligence
  • Resistell AG — Resistell is a antibiotic resistance test.
  • iThera Medical — Explore optoacoustic imaging technology for non-invasive in vivo visualization and quantification of disease-related tissue biomarkers.
Show all investments...

Andera Partners
VC Fund · Paris, Ile-de-France, France

Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP) As heir to the traditions and values that have ensured the success of the Rothschild family for 250 years, the Edmond de Rothschild Group has established itself over time as a leading player in European finance. Its activities are grouped around two major areas:Private Banking and Asset Management. The Group offers wealthy families, entrepreneurs, and large institutions a full range of solutions combining a culture of tailored solutions, stability, performance, and innovation. The Edmond de Rothschild Group’s offering is characterised by strong convictions, with the desire to guarantee to each of its customers: A unique, close relationship, underpinned by the know-how and the variety of expertise of a large international group; Autonomous, experienced teams, who anticipate economic trends and innovate to establish long-term performance; The recognised stability, strength, and independence of a family-owned financial group. Founded by Baron Edmond de Rothschild in 1953, the Group has been chaired by his son, Baron Benjamin de Rothschild, since 1997.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series B, Private Equity, Funding Round
  • France, United States, Germany

Portfolio highlights

  • MMI — The future of Microsurgery: microinstruments that expand the possibilities of surgical interventions. Wristed robotic microinstruments for unprecedented results in microsurgery.
  • Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
  • Mineralys Therapeutics — Evolving science is revealing the importance of aldosterone in cardio-renal-metabolic diseases.We are focused on improving outcomes for people managing hypertension, CKD and related diseases that are driven by dysregulated aldosterone. About Aldosterone
Show all investments...

Seed Fonds Aachen
VC Fund · Aachen, Nordrhein-Westfalen, Germany

Seed Fonds has a strong competence network with national and international investors, business angels & expertes from the industry. They are specialized in the development of comprehensive financing models offering stability and development opportunities on the long term.

Show more...

Investment focus

  • Biotechnology, Medical, Health Care
  • Funding Round, Seed, Series A
  • Germany

Portfolio highlights

  • miacosa — miacosa.de is operated by the Endorsed Goods GmbH. miacosa.de is a social shopping concept from Germany based in Cologne. Social Shopping the miacosa way means that members select their personal shopping team of experts and celebrities that present products they love on miacosa.de Miacosa is for members only. The free service starts with productsfrom the fields of Health Style, Home & Living, Kitchen and fashion accessories.
  • Hemovent — ​​​Based in Aachen, Germany, Hemovent is a privately held medical technology company that is developing a portable ECMO (Extra Corporeal Membrane Oxygenation) unit. Hemovent was founded by serial entrepreneur, Christof Lenz and Oliver Marseille, inventors of the company’s proprietary platform. It is the goal of the company to develop aninnovative solution, with precision and craftsmanship, that will aide patients with lung and heart function while allowing them to be mobile.
  • aquila biolabs — aquila biolabs is a German technology company focusing on the development of innovative laboratory devices for the analysis of shake-flask fermentations in biotechnological, chemical and pharmaceutical research and development.
Show all investments...

Gilde Healthcare
VC Fund · Utrecht, Utrecht, The Netherlands

Gilde Healthcare is a specialized European healthcare investor managing two business lines: a lower mid-market buy-out fund and a venture & growth capital fund. It has over €800 million ($900 million) under management and is actively looking to lead new investments in digital health, diagnostics, medical devices, therapeutics and healthcareservices. Gilde successfully builds healthcare businesses across Europe and US, investing up to €35 million in a single portfolio company.

Show more...

Investment focus

  • Biotechnology, Health Care, Medical
  • Series B, Series C, Series A
  • United States, The Netherlands, Germany

Portfolio highlights

  • FIRE1 — FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
  • ProVerum Medical — The ProVee stent from Proverum Medical uses 3-D geometry which mirrors and engages with the anatomy of the prostate. The system alleviates Lower Urinary Tract Symptoms (LUTS) by opening the prostatic urethra, applying radial force to the prostatic lobes.
  • Endovascular Engineering — Endovascular Engineering is a preclinical stage company developing novel mechanical thrombectomy solutions to address peripheral indications.
Show all investments...

Lowercarbon Capital
VC Fund · New York, New York, United States

Lowercarbon Capital backs kickass companies slashing CO2 emissions, sucking carbon out of the sky, and buying us time to unf**k the planet.

Show more...

Investment focus

  • Renewable Energy, Energy, Biotechnology
  • Seed, Series A, Series B
  • United States, United Kingdom, France

Portfolio highlights

  • Lasso — Tender Food is a plant-based and cultured meat company in the Greater Boston Area, a hub for biotech research and innovation. It specializes in creating alternative meats with authentic textures.
  • Arc Boats — Arc is electrifying the marine industry, starting with recreational boating.
  • Avalanche Energy — Avalanche Energy operates as a fusion energy start-up.
Show all investments...

Good Seed Ventures
VC Fund · Rheine, Nordrhein-Westfalen, Germany

Good Seed Ventures is a Venture Capital firm that exclusively invests in sustainable food tech.

Show more...

Investment focus

  • Food and Beverage, Food Processing, Biotechnology
  • Seed, Series A, Pre-Seed
  • Germany, Israel, United States

Portfolio highlights

  • Lovely Day Foods — We harness the power of plants and cutting-edge technology to crack the egg.
  • Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
  • Nosh Biofoods — We create nutritional and highly functional proteins from non-GMO fungi. Our proprietary ferementation process is minimal, scalable, and sustainable.
Show all investments...

Ananda Impact Ventures
VC Fund · Munich, Bayern, Germany · 6 investments in the past 12 months

We are the home for entrepreneurs with a big vision who want to create something less ordinary. Something that matters. For all of us.

Show more...

Investment focus

  • Health Care, Software, Information Technology
  • Seed, Funding Round, Series A
  • Germany, United Kingdom, Finland

Portfolio highlights

  • Elio — Putting leading scientific data into context, to enable others to respond to climate change’s dynamism and act on solutions with confidence.
  • Ocean Ledger — Precision analytics to design, implement & monitor coastal mitigation and adaptation.
  • NatureMetrics — NatureMetrics is the World-Leading provider of Biodiversity monitoring data, using eDNA surveys, metabarcoding & more. Book your demo today!
Show all investments...

EQT Life Sciences
VC Fund · Amsterdam, Noord-Holland, The Netherlands

Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.

Show more...

Investment focus

  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, The Netherlands, Switzerland

Portfolio highlights

  • Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
  • Mosanna Therapeutics — Mosanna is a Biotech company based in Basel with a commitment to improving patient outcomes and quality of life in high unmet need diseases, applying a precision medicine approach.
  • Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
Show all investments...

TVM Capital
VC Fund · Munich, Bayern, Germany

TVM Capital Life Science is one of the transatlantic Venture Capital pioneers with teams based in North America and Europe.

Show more...

Investment focus

  • Biotechnology, Health Care, Pharmaceutical
  • Series B, Funding Round, Series C
  • United States, Germany, United Kingdom

Portfolio highlights

  • Definiens — Definiens is the provider of image analysis and data mining solutions for quantitative digital pathology in the life sciences, diagnostic biomarkers and healthcare industries. Definiens software provides detailed readouts from whole tissue slides, cell-based assays and full body scans and allows correlating this information with data derived fromother sources. By automating analysis workflows, Definiens helps pharmaceutical and biotechnology companies, research institutions, clinical service organizations and pathologists to generate new knowledge and supports better decisions in research, diagnostics and therapy. Definiens’ vision is to open new fields of research, to contribute to development of personalized medicine and to significantly improve the quality of patients’ lives. Definiens is headquartered in Munich, Germany, and has offices throughout the United States.
  • Lamab Biologics — Lamab Biologics operates as a biotechnology company. Lamab Biologics develop first-in-class monoclonal antibody prophylactic therapeutic targeting IgE, a key mediator for allergic diseases.
  • Rapid Micro Biosystems — Rapid Micro Biosystems provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biotechnology, and personal care products. It offers the Growth Direct System, a non-destructive method for microbial enumeration. The company was formerly known as Genomic Profiling Systems and changed its name to RapidMicro Biosystems in 2007. Rapid Micro Biosystems was founded in 2006 and is based in Bedford, Massachusetts.
Show all investments...

M Ventures
VC Fund · Amsterdam, Noord-Holland, The Netherlands

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Show more...

Investment focus

  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Seed
  • United States, United Kingdom, Switzerland

Portfolio highlights

  • Akili Interactive Labs — Akili Interactive is a prescription digital medicine company combining scientific and clinical rigor with the ingenuity of the tech industry to reinvent medicine.
  • NanoSyrinx — NanoSyrinx is an award-winning, discovery stage biotechnology company based in the UK. We are using synthetic biology approaches to develop protein nanosyringes as a completely novel modality for intracellular delivery of protein and peptide biologic drugs.
  • Scipio Bioscience — Scipio Bioscience, a Paris-based biotechnology company, provides a novel sample preparation solutionfor single-cell studies, in the form of benchtop kits, for use in sequencing applications in clinical and basic research, in particular transcriptomics.
Show all investments...

Possible Ventures
VC Fund · Munich, Bayern, Germany

Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.

Show more...

Investment focus

  • Software, Biotechnology, Information Technology
  • Seed, Pre-Seed, Series A
  • Germany, Australia, United States

Portfolio highlights

  • Telura — Telura is a deep-tech business that uses next-generation drilling to enable geothermal energy everywhere. Telura creates electric impulse drilling technology, which breaks rock from within using high-voltage pulses.
  • EntryLevel — Learn in an affordable, peer-driven environment over 6 weeks with mentors from top companies across the world such as Atlassian, Wise and more.
  • VSPARTICLE — VSPARTICLE develops nanoparticle generators for various applications such as sensors, batteries, catalysis, solar cells, healthcare, additive manufacturing, nano safety, and more. It also enables research and industry to generate new materials at the push of a button.They specialize in nanoparticle production and integration. The technologyspeeds up the developments of customers by producing the desired nanoparticles on location and integrate them directly in the final product. VSPARTICLE was founded in 2014 and is headquartered in Delft, The Netherlands.
Show all investments...

Global Asset Fund
VC Fund · Landshut, Bayern, Germany

Global Asset Fund is a private equity firm based in Germany that finances early and later stage venture investments. The fund enables the development of products and technologies that address a growing market of tomorrow.

Show more...

Investment focus

  • Medical, Therapeutics, Biotechnology
  • Series A, Series B, Funding Round
  • Germany

Portfolio highlights

  • Siltectra — SILTECTRA is a high-tech company specializing in kerfless wafering and thinning, an innovative new technology for manufacturing wafers. Kerfless wafering by SILTECTRA is a platform technology which can be used in a wide variety of industries and for many different materials.
  • Isarna Therapeutics — Isarna Therapeutics has an unmatched commitment to developing selective TGF-β inhibitors to effectively treat ophthalmic diseases. They are advancing a unique pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcomes.
Show all investments...

Think.Health
VC Fund · Fürstenfeldbruck, Bayern, Germany

Think.Health invests as a boutique risk-taker in healthcare ventures. We continuously seek innovations and disruptive business models in digital healthcare, medical technologies and health service providers,

Show more...

Investment focus

  • Health Care, Biotechnology, Medical Device
  • Seed, Series A, Series B
  • Germany, United States, Switzerland

Portfolio highlights

  • Robeaute — Redesigning the future of neurosurgery by creating the new standard device that will provide surgeons with seamless access to delicate areas of the brain parenchyma and with real-time data.
  • Inflammatix — Inflammatix develops rapid point of care diagnostic tests by reading the immune system, and resolves major clinical health challenges.
  • Sphingotec GmbH — Improving patient outcomes with innovative diagnostics for critical care: Actionable insights in real-time
Show all investments...

LBBW VC
VC Fund · Stuttgart, Baden-Wurttemberg, Germany

We help brilliant teams with a strong moat to establish visionary market leaders.

Show more...

Investment focus

  • Software, Biotechnology, Health Care
  • Series A, Seed, Series B
  • Germany, United Kingdom, Switzerland

Portfolio highlights

  • CorTec — Reliable products for active implantable device development. We realize your next project with you and offer individual solutions that meet your specific requirements for Medical Devices, especially in neurotechnology.
  • Code Intelligence — Always be a step ahead. Find and fix vulnerabilities before others do. Run automated security tests with each pull request!
  • Workdry International — Workdry International provides designed water and wastewater management and treatment solutions.
Show all investments...

Counteract
VC Fund · London, England, United Kingdom · 2 investments in the past 12 months

Carbon removal innovation through research, development and early stage investment

Show more...

Investment focus

  • Environmental Engineering, CleanTech, AgTech
  • Seed, Series A, Pre-Seed
  • United Kingdom, United States, Germany

Portfolio highlights

  • Mote — Mote is creating new gasification technologies to produce cost-competitive carbon-negative hydrogen. We offer hydrogen at scale with our uniquely integrated gasification plant.
  • CREW Carbon — CREW Carbon is on a mission to remove CO2 across Earth's water cycle by first leveraging wastewater systems as a scalable, deployable solution today. We empower the global wastewater sector to lead the fight against climate change.
  • Chloris Geospatial — Chloris Geospatial is able to provide answers today to critical natural capital issues. Chloris Geospatial provides innovative measurements of natural capital that use cutting-edge remote sensing, machine learning, and ecological science.
Show all investments...

SFO
VC Fund · Weingarten, Baden-Wurttemberg, Germany

SFO is an entrepreneur from the start-up environment and medium-sized companies. SFO offers complementary expertise, reliable capital, and an effective network.

Show more...

Investment focus

  • Food and Beverage, B2C, Pet
  • Seed, Pre-Seed, Series A
  • Germany

Portfolio highlights

  • Younikat — VEGDOG - vegan dog food is the first 100% vegetable and gluten-free complete feed for dogs, which was developed in a one-year development phase in cooperation with specialist veterinarians and specialist laboratories due to a feed allergy in our dog Nelson.
  • ecoLocked — ecoLocked is your partner to create a climate-positive built environment. We develop CO2-optimized recipes for concrete based on carbon-negative biochar admixes. Our admixes allow to store captured CO2 in buildings, reduce direct emissions from concrete production, and provide multiple functional benefits, such as improved thermal insulation.
  • ProteinDistillery — ProteinDistillery: The Future of Sustainable Protein Production. We transform industrial side-streams into functional protein ingredients.
Show all investments...

UVC Partners
VC Fund · Munich, Bayern, Germany

UVC Partners is a Munich- and Berlin-based early-stage venture capital firm that invests in technology-based startups in the areas of enterprise software, industrial technologies, and mobility. The fund typically invests between € 0.5 - 10m initially and up to € 20m in total per company.

Show more...

Investment focus

  • Software, Information Technology, SaaS
  • Seed, Series A, Series B
  • Germany, Switzerland, Denmark

Portfolio highlights

  • planqc — Planqc quantum processors use atoms in artificial crystals of light - the fastest way to scale to useful quantum advantage.
  • Synera — Accelerate product development and unlock potential with powerful workflows that connect your data, tools and teams.
  • fruitcore robotics — fruitcore robotics is a robotic system that leverages intelligent software and innovative mechatronics.
Show all investments...

Agronomics
VC Fund · Douglas, South Lanarkshire, United Kingdom

Venture capital investment can raise funds for your small business. Venture Capital Firms in the UK like Agronomics is a biotech venture capital firm which invest into the clean meat sector.

Show more...

Investment focus

  • Biotechnology, Food and Beverage, Food Processing
  • Seed, Series A, Series B
  • United States, Finland, Germany

Portfolio highlights

  • GALY — GALY biocrafts premium cocoa and cotton with quality, traceability, and scalable supply for modern brands.
  • Onego Bio — Onego Bio is a cell ag company, specialized in animal-free egg white protein. We produce bioalbumen with an innovative precision fermentation process.
  • Liberation Labs — Liberation Labs believe that by innovating technology, It can free the world from the costs of industrialized agriculture and unlock a new era of accessible, healthy foods. The mission is to make precision fermentation by commercializing purpose-built manufacturing facilities for industrial biotech.
Show all investments...

Seventure Partners
VC Fund · Paris, Ile-de-France, France

Seventure Partners is a French venture capital firm targeting in Tech/Digital and Life Sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 1 billion undermanagement as of December 31, 2023. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.The different funds/verticals on which Seventure Partners are focusing on today: - Life Sciences : Biotech, Healthcare, Nutrition - Tech/Digital : B2B SaaS, Fintech, Retailtech, Cybersecurity - Sports & Wellbeing - Blue Economy

Show more...

Investment focus

  • Biotechnology, Health Care, Software
  • Series A, Funding Round, Series B
  • France, United States, Germany

Portfolio highlights

  • FIRE1 — FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
  • Hepster — hepster, die Onlineversicherung, flexibel, sicher und immer 100% digital.
  • BAOUW / Outdoor Organic Nutrition — A raw, healthy, and natural diet made up of energy gels, energy bars, and energy fruit purees.
Show all investments...
Investors by industry
Investors by country
VC (Venture Capital) Funds in Germany by industry

Contact investors today

Find who invests in your industry, stage, and country in 5 minutes.

Find investors — It's Free!